AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32746071 — intervention group
Group type: COMPARATOR
Intervention: Control group self-managing the training session
Number of subjects: 24
Study 32450915 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC plus hydroxychloroquine monotherapy
Number of subjects: 0
Study 32450915 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC plus hydroxychloroquine and azithromycin
Number of subjects: 0
Study 32450915 — intervention group
Group type: COMPARATOR
Intervention: SOC alone
Number of subjects: 0
Study 34993571 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein diet (CRHP, E%: CH30/P30/F40)
Number of subjects: 72
Study 34993571 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes diet (CD, E%: CH50/P17/F33)
Number of subjects: 72
Study 34085588 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 54
Study 34085588 — intervention group
Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 54
Study 34085588 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 54
Study 32503948 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 2261
Study 32503948 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 2261
Study 36014930 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth lifestyle coaching programme
Number of subjects: 170
Study 36014930 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 170
Study 33549732 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy intervention
Number of subjects: 100
Study 33549732 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 100
Study 32843527 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA mutated tumors
Number of subjects: 1253
Study 32843527 — intervention group
Group type: COMPARATOR
Intervention: PIK3CA wild-type tumors
Number of subjects: 1253
Study 32843527 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2-enriched/PIK3CA mutated tumors
Number of subjects: 1253
Study 32843527 — intervention group
Group type: COMPARATOR
Intervention: HER2-enriched/PIK3CA wild-type tumors
Number of subjects: 1253
Study 32843527 — intervention group
Group type: EXPERIMENTAL
Intervention: High TILs (10% increment)
Number of subjects: 1253
Study 32843527 — intervention group
Group type: EXPERIMENTAL
Intervention: PDCD1 expression
Number of subjects: 1253
Study 32843527 — intervention group
Group type: EXPERIMENTAL
Intervention: MYBL2 expression
Number of subjects: 1253
Study 35779110 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) + pelvic floor muscle training (PFMT) + anticholinergic + beta3‐agonist
Number of subjects: 70
Study 35779110 — intervention group
Group type: COMPARATOR
Intervention: Behavioral therapy (BT) + anticholinergic + beta3‐agonist
Number of subjects: 70
Study 34969300 — intervention group
Group type: EXPERIMENTAL
Intervention: Research data informed an opera on Veteran recovery
Number of subjects: 280
Study 35851816 — intervention group
Group type: EXPERIMENTAL
Intervention: Deconstruction into key steps (DIKS)
Number of subjects: 126
Study 35851816 — intervention group
Group type: COMPARATOR
Intervention: Standard course (Control Group)
Number of subjects: 126
Study 34334330 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 53
Study 34334330 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib with Rituximab (IR)
Number of subjects: 53
Study 34334330 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine-Rituximab (BR)
Number of subjects: 53
Study 35548067 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day discharge (SDD) group
Number of subjects: 84
Study 35548067 — intervention group
Group type: COMPARATOR
Intervention: Inpatient group
Number of subjects: 84
Study 32166544 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic sedoanalgesia (intravenous remifentanil/fentanyl ± intravenous midazolam ± intravenous acetaminophen/nonsteroidal anti‐inflammatory drugs) + subcutaneous anesthesia (lidocaine)
Number of subjects: 14
Study 32166544 — intervention group
Group type: COMPARATOR
Intervention: Mild systemic sedoanalgesia (oral solution morphine sulfate + intravenous midazolam + intravenous acetaminophen) + both subcutaneous and subcapsular anesthesia (mepivacaine + bupivacaine)
Number of subjects: 14
Study 616854037 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear Acupuncture (EA) for 20 min
Number of subjects: 80
Study 616854037 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PG) treated with detuned ultrasound
Number of subjects: 80
Study 616854037 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear Acupuncture (EA)
Number of subjects: 80
Study 616854037 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 80
Study 33802381 — intervention group
Group type: COMPARATOR
Intervention: Resveratrol (lower dose)
Number of subjects: 21
Study 33802381 — intervention group
Group type: COMPARATOR
Intervention: Resveratrol (higher dose)
Number of subjects: 21
Study 33802381 — intervention group
Group type: COMPARATOR
Intervention: Luteolin (lower dose)
Number of subjects: 21
Study 33802381 — intervention group
Group type: COMPARATOR
Intervention: Luteolin (higher dose)
Number of subjects: 21
Study 33802381 — intervention group
Group type: COMPARATOR
Intervention: Fisetin (lower dose)
Number of subjects: 21
Study 33802381 — intervention group
Group type: COMPARATOR
Intervention: Fisetin (higher dose)
Number of subjects: 21
Study 32126490 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-responsive neurostimulation (RNS® System)
Number of subjects: 191
Study 34958337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports Stars Brazil (modified sports intervention)
Number of subjects: 76
Study 34958337 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 76
Study 35102967 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine buccal infiltration
Number of subjects: 46
Study 35102967 — intervention group
Group type: COMPARATOR
Intervention: 2% lignocaine inferior alveolar nerve block (IANB)
Number of subjects: 46
Study 35102967 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior assessment
Number of subjects: 46
Study 32470438 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (75-100 mg/kg per day)
Number of subjects: 393
Study 32470438 — intervention group
Group type: COMPARATOR
Intervention: Deferasirox (20-40 mg/kg per day)
Number of subjects: 393
Study 32470438 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 393
Study 32470438 — intervention group
Group type: COMPARATOR
Intervention: Deferasirox
Number of subjects: 393
Study 35543129 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 9
Study 34452714 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM)
Number of subjects: 196
Study 34452714 — intervention group
Group type: COMPARATOR
Intervention: Classic group (control)
Number of subjects: 196
Study 34313812 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (TOF) 5 mg orally twice a day
Number of subjects: 66
Study 34313812 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) 10 mg weekly
Number of subjects: 66
Study 33055139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Closed-Loop (HCL)
Number of subjects: 120
Study 33055139 — intervention group
Group type: COMPARATOR
Intervention: Control (user-determined insulin dosing)
Number of subjects: 120
Study 35940596 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic drape
Number of subjects: 14
Study 35940596 — intervention group
Group type: COMPARATOR
Intervention: No drape (control)
Number of subjects: 14
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with modified oxaliplatin, leucovorin, and fluorouracil (FOLFOX)
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with carboplatin‐paclitaxel (CP)
Number of subjects: 241
Study 34077237 — intervention group
Group type: COMPARATOR
Intervention: PET nonresponders who crossed over to CP after induction FOLFOX
Number of subjects: 241
Study 34077237 — intervention group
Group type: COMPARATOR
Intervention: PET nonresponders who changed to FOLFOX after induction CP
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: PET responders to induction FOLFOX during chemoradiation
Number of subjects: 241
Study 34077237 — intervention group
Group type: COMPARATOR
Intervention: PET responders to induction CP during chemoradiation
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: PET responders to induction FOLFOX
Number of subjects: 241
Study 33185339 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted antibiotic therapy
Number of subjects: 124
Study 33185339 — intervention group
Group type: EXPERIMENTAL
Intervention: Local peloid therapy
Number of subjects: 124
Study 33185339 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibromagnetotherapy
Number of subjects: 124
Study 33185339 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 124
Study 35708162 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐criticism intervention
Number of subjects: 130
Study 35708162 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media curation
Number of subjects: 130
Study 35708162 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 130
Study 34611700 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted anal fistula treatment (VAAFT)
Number of subjects: 45
Study 34611700 — intervention group
Group type: COMPARATOR
Intervention: Fistulectomy and sphincter repair (FSR)
Number of subjects: 45
Study 34611700 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (VAAFT and FSR)
Number of subjects: 45
Study 32546278 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,3′-diindolylmethane (DIM)
Number of subjects: 2
Study 32546278 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (COX2 selective inhibitor)
Number of subjects: 2
Study 32546278 — intervention group
Group type: COMPARATOR
Intervention: PGE2 treatment
Number of subjects: 2
Study 32546278 — intervention group
Group type: COMPARATOR
Intervention: Blockade of RhoA/ROCK1 pathway
Number of subjects: 2
Study 32546278 — intervention group
Group type: EXPERIMENTAL
Intervention: DIM
Number of subjects: 2
Study 34645251 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 120
Study 34645251 — intervention group
Group type: COMPARATOR
Intervention: Intermittent hemodialysis (IHD)
Number of subjects: 120
Study 32957420 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent physical exercise program with a Mediterranean diet
Number of subjects: 0
Study 32957420 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 0
Study 35969032 — intervention group
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Number of subjects: 0
Study 35969032 — intervention group
Group type: COMPARATOR
Intervention: Cabozantinib or Vandetanib
Number of subjects: 0
Study 33967255 — intervention group
Group type: EXPERIMENTAL
Intervention: PROVHILO strategy
Number of subjects: 20
Study 33967255 — intervention group
Group type: COMPARATOR
Intervention: iPROVE strategy
Number of subjects: 20
Study 32404378 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (HSD)
Number of subjects: 20
Study 32404378 — intervention group
Group type: COMPARATOR
Intervention: Low-salt diet
Number of subjects: 20
Study 36272105 — intervention group
Group type: EXPERIMENTAL
Intervention: Every-other-day strategy (EOD group)
Number of subjects: 450
Study 36272105 — intervention group
Group type: EXPERIMENTAL
Intervention: Fertile window monitoring (FWM group)
Number of subjects: 450
Study 36272105 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 450
Study 32871554 — intervention group
Group type: EXPERIMENTAL
Intervention: High-compression (HC) garments
Number of subjects: 10
Study 32871554 — intervention group
Group type: COMPARATOR
Intervention: Loose-fitting gym attire (CON)
Number of subjects: 10
Study 32871554 — intervention group
Group type: COMPARATOR
Intervention: Low-compression (LC) garments
Number of subjects: 10
Study 33737653 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolomic biomarkers (valine, leucine, carnitine, glutamic acid)
Number of subjects: 1853
Study 33737653 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine (confirmed by 2-sample Mendelian randomisation)
Number of subjects: 1853
Study 33737653 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomisation approach
Number of subjects: 1853
Study 33737653 — intervention group
Group type: EXPERIMENTAL
Intervention: Valine and leucine
Number of subjects: 1853
Study 33737653 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamic acid and alanine
Number of subjects: 1853
Study 32113008 — intervention group
Group type: EXPERIMENTAL
Intervention: TG5 (trained at 5% of maximum voluntary isometric contraction of the PFM)
Number of subjects: 30
Study 32113008 — intervention group
Group type: EXPERIMENTAL
Intervention: TG10 (trained at 10% of maximum voluntary isometric contraction of the PFM)
Number of subjects: 30
Study 32113008 — intervention group
Group type: COMPARATOR
Intervention: CG (control group, no specific training for the PFM)
Number of subjects: 30
Study 34863994 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin (1000 mg daily) + antiviral drugs (remdesivir or favipiravir)
Number of subjects: 60
Study 34863994 — intervention group
Group type: COMPARATOR
Intervention: Antiviral drugs (remdesivir or favipiravir)
Number of subjects: 60
Study 33218517 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education (PNE) program
Number of subjects: 30
Study 35909493 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) combined with conventional rehabilitation therapy (CRT)
Number of subjects: 40
Study 35909493 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation therapy (CRT) alone
Number of subjects: 40
Study 32746877 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO)
Number of subjects: 60
Study 32746877 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO) with recruitment manoeuvres (RM)
Number of subjects: 60
Study 35103380 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coach supervised by a virtual care team (high intensity)
Number of subjects: 52
Study 35103380 — intervention group
Group type: COMPARATOR
Intervention: Self‐directed learning (low intensity)
Number of subjects: 52
Study 35320282 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cytology
Number of subjects: 166
Study 35320282 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell block preparation
Number of subjects: 166
Study 35320282 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined conventional cytology and cell block preparation
Number of subjects: 166
Study 32981337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction intervention
Number of subjects: 0
Study 35726151 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS current applied over the primary motor cortex (M1) for 20 min at 2 mA
Number of subjects: 13
Study 35726151 — intervention group
Group type: COMPARATOR
Intervention: SHAM intervention (current applied for 30 s then terminated)
Number of subjects: 13
Study 33677529 — intervention group
Group type: EXPERIMENTAL
Intervention: Population Health Management (PHM) approach including electronic health record query, physician review, letter invitation, and telephone follow-up.
Number of subjects: 599
Study 33677529 — intervention group
Group type: EXPERIMENTAL
Intervention: Active respondents
Number of subjects: 599
Study 33677529 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive respondents
Number of subjects: 599
Study 33677529 — intervention group
Group type: EXPERIMENTAL
Intervention: Study participants
Number of subjects: 599
Study 32134854 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 50
Study 32134854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34599663 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatment (specifics not provided)
Number of subjects: 200
Study 34599663 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment disorder (AD) diagnosis
Number of subjects: 200
Study 34599663 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment status
Number of subjects: 200
Study 34599663 — intervention group
Group type: EXPERIMENTAL
Intervention: Time since diagnosis
Number of subjects: 200
Study 32164888 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice daily
Number of subjects: 18073
Study 32164888 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18073
Study 35840916 — intervention group
Group type: EXPERIMENTAL
Intervention: MG plus A-MRI
Number of subjects: 198
Study 35840916 — intervention group
Group type: COMPARATOR
Intervention: MG alone
Number of subjects: 198
Study 33990939 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week martial arts training programme
Number of subjects: 283
Study 33990939 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 283
Study 32340075 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrodiathermy
Number of subjects: 192
Study 32340075 — intervention group
Group type: COMPARATOR
Intervention: Helium thermal coagulator
Number of subjects: 192
Study 35384254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent (DTS)
Number of subjects: 3146
Study 35384254 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting Orsiro stent (SES)
Number of subjects: 3146
Study 32409485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenobamate 200 mg/d
Number of subjects: 222
Study 32409485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 36114009 — intervention group
Group type: COMPARATOR
Intervention: Seven additional vincristine and dexamethasone (VD) pulses (Control group)
Number of subjects: 263
Study 36114009 — intervention group
Group type: EXPERIMENTAL
Intervention: No additional vincristine and dexamethasone (VD) pulses (Experimental group)
Number of subjects: 263
Study 34329984 — intervention group
Group type: EXPERIMENTAL
Intervention: HS+BT group (1,000 mg/kg betaine)
Number of subjects: 150
Study 34329984 — intervention group
Group type: EXPERIMENTAL
Intervention: HS group (no betaine)
Number of subjects: 150
Study 34329984 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard finisher feed under thermoneutral condition)
Number of subjects: 150
Study 32182274 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculin skin testing (TST) with induration cut-off ≥5mm
Number of subjects: 2985
Study 32182274 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculin skin testing (TST) with induration cut-off ≥10mm
Number of subjects: 2985
Study 32182274 — intervention group
Group type: COMPARATOR
Intervention: Household contacts in Mangaung compared to Capricorn
Number of subjects: 2985
Study 32182274 — intervention group
Group type: COMPARATOR
Intervention: Household contacts of HIV-positive index cases
Number of subjects: 2985
Study 35373026 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 15 mg subcutaneous injection
Number of subjects: 12
Study 35373026 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 50 mg subcutaneous injection
Number of subjects: 12
Study 35373026 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 5 mg subcutaneous injection
Number of subjects: 12
Study 35373026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 32532230 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus ramucirumab (wPTX + RAM)
Number of subjects: 105
Study 32532230 — intervention group
Group type: COMPARATOR
Intervention: Weekly nab-paclitaxel plus ramucirumab (w-nab-PTX + RAM)
Number of subjects: 105
Study 33524627 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-row fixation
Number of subjects: 68
Study 33524627 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-row suture bridge fixation
Number of subjects: 68
Study 33524627 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 68
Study 32387214 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Layer Intestinal Anastomosis (SLIA)
Number of subjects: 106
Study 32387214 — intervention group
Group type: COMPARATOR
Intervention: Double Layer Intestinal Anastomosis (DLIA)
Number of subjects: 106
Study 35757181 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplement (NingXia RedⓇ), 60 ml daily for 60 days
Number of subjects: 155
Study 35757181 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study 32727335 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids and nano-curcumin combination
Number of subjects: 80
Study 32727335 — intervention group
Group type: COMPARATOR
Intervention: n-3 fatty acids
Number of subjects: 80
Study 32727335 — intervention group
Group type: COMPARATOR
Intervention: nano-curcumin
Number of subjects: 80
Study 32727335 — intervention group
Group type: COMPARATOR
Intervention: n-3 fatty acids and curcumin placebo
Number of subjects: 80
Study 35294298 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga breathing exercises (prāṇāyāma) over an observation period of 6 months
Number of subjects: 120
Study 35294298 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yoga intervention)
Number of subjects: 120
Study 33099665 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue (n=216)
Number of subjects: 625
Study 33099665 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-gripping mesh (n=202)
Number of subjects: 625
Study 33099665 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-absorbable 3-0 polypropylene sutures (n=216)
Number of subjects: 625
Study 32238297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele‐BA (Behavioral Activation)
Number of subjects: 89
Study 32238297 — intervention group
Group type: COMPARATOR
Intervention: Tele‐FV (Friendly Visits)
Number of subjects: 89
Study 35624347 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat added to standard of care (SOC)
Number of subjects: 0